Search Within

Jedd D Wolchok

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (61)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (139)
  2. Epidemiology and Biostatistics (139)
  3. GSK Faculty (139)
  4. Melanoma and Immunotherapeutics Service (139)
  5. Solid Tumor Oncology Division (139)
  6. Biostatistics Service (127)

More Groups

People
  1. Katherine Panageas (92)
  2. Paul Chapman (61)
  3. Michael Postow (48)
  4. Margaret Callahan (40)
  5. Jianda Yuan (38)
  6. Taha Merghoub (34)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (10)
  4. 2021 (7)
  5. 2020 (10)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (43)
  2. Journal for ImmunoTherapy of Cancer (12)
  3. Cancer Research (10)
  4. Clinical Cancer Research (9)
  5. Nature (5)
  6. Cancer Immunology Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. American Association for Cancer Research (24)
  3. Biomed Central Ltd (12)
  4. Nature Publishing Group (9)
  5. Cell Press (5)
  6. Lippincott Williams & Wilkins (5)

More Publishers

Results (139)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Adipocyte-derived lipids mediate melanoma progression via FATP proteins
    Journal Article

    Zhang, M.; Di Martino, J. S.; Bowman, R. L.; Campbell, N. R.; Baksh, S. C.; Simon-Vermot, T.; Kim, I. S.; Haldeman, P.; Mondal, C.; Yong-Gonzales, V.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Nathanson, T.; Rizvi, H.; Creelan, B. C.; Sanchez-Vega, F.; Ahuja, A.; Ni, A.; Novik, J. B.; Mangarin, L. M. B.; Abu-Akeel, M.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma
    Journal Article

    Shoushtari, A. N.; Friedman, C. F.; Navid-Azarbaijani, P.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Panageas, K. S.; Wolchok, J. D.; Chapman, P. B.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save